- Report
- December 2022
- 217 Pages
Brazil
From €3798EUR$3,995USD£3,191GBP
- Report
- December 2022
- 217 Pages
Japan
From €3798EUR$3,995USD£3,191GBP
- Report
- December 2023
- 10 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- July 2022
- 9 Pages
Global
From €2995EUR$3,150USD£2,516GBP
- Report
- September 2024
- 260 Pages
Global
From €2524EUR$2,655USD£2,120GBP
- Report
- October 2022
- 282 Pages
Global
From €3394EUR$3,570USD£2,851GBP
Embolization is a minimally invasive procedure used in cardiology to block the flow of blood to a specific area of the body. It is commonly used to treat aneurysms, arteriovenous malformations, and other vascular diseases. The procedure involves the insertion of a catheter into an artery and the injection of a substance, such as a coil, plug, or glue, to block the flow of blood. This procedure is often used as an alternative to open surgery, as it is less invasive and has fewer risks.
The embolization market is a rapidly growing segment of the cardiology industry. It is driven by the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. The market is expected to continue to grow in the coming years, as more patients opt for embolization procedures over traditional open surgery.
Some of the major companies in the embolization market include Boston Scientific, Cook Medical, Medtronic, Terumo Corporation, Merit Medical Systems, and Stryker Corporation. Show Less Read more